Prior Auth Required

0346U - Investigational Beta amyloid, Aβ40 and Aβ42 by liquid chromatography with

This procedure appears on the selected insurer prior authorization source.

Prior authorizationPrior Auth Required
Procedure / ServiceInvestigational Beta amyloid, Aβ40 and Aβ42 by liquid chromatography with
Procedure / Service Description

responding to immune checkpointinhibitor therapy - or not NASH Investigational 0346U Beta amyloid, Aβ40 and Aβ42 by liquid chromatography with Potential tandem mass spectrometry (LC- MS/MS), ratio, plasma

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.